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ABSTRACT
[2.2.2]-Diazabicyclic alkaloids are a natural product family with diverse biological
activities. The development of a synthetic methods towards the synthesis of
[2.2.2]-diazabicyclic alkaloids is described.
I: Diels-Alder Reactions of a C2-Carboxy Pyrazinone
Using an N-heterocyclic carbene catalyzed aroylation of a proline 3,5dichloropyrazinone, a synthetic route to C2-carboxy pyrazinones was developed
to study the intermolecular and intramolecular Diels-Alder reactions of these
compounds to form the bicyclo[2.2.2]diazaoctane core. Studies showed that
having oxidation present α to the pyrazinone ring did not provide any significant
increase in reactivity or selectivity as compared to pyrazinones without oxidation
α to the ring. In some cases, the oxidation completely hindered reactivity.
II: Intermolecular Diels-Alder Reaction of a Proline Derived Pyrazinone with
Symmetric Dienophiles
The intermolecular Diels-Alder reaction of a proline derived pyrazinone with
maleic anhydride allows for selective access the anti-C19 isomer of the [2.2.2]diazabicylic alkaloid. Selective opening of the resulting anhydride cycloadduct
followed by radical excision of the C18 carboxy group provides a known
intermediate in the Williams’ synthesis of Brevianamide B. The overall route
provides the desired anti-C19 isomer of the methyl ester product in 6 steps and
12% overall yield from the proline derived pyrazinone. This route constitutes a 15
step formal synthesis of Brevianamide B.

TABLE OF CONTENTS
Acknowledgements

ii

Dedications

iii

Chapter 1.

An Introduction to [2.2.2]-Diazabicyclic Alkaloids

1

Chapter 2.

Diels-Alder Reactions of a C2-Carboxy Pyrazinone

9

Chapter 3.

Intermolecular Diels-Alder Reaction of a Pyrazinone
with Symmetric Dienophiles

22

References

56

i

ACKNOWLEDGEMENTS
First and foremost, I would like to express my deepest gratitude to my graduate
research advisor Dr. Jonathan Scheerer for his guidance, patience, and
thoughtful criticism while I conducted this research. I am forever indebted to him
for the knowledge and understanding he has imparted to me about the art of total
synthesis during my time as a master’s student. I can honestly say I would not be
headed to the University of Michigan to start working on my Ph.D. in organic
synthesis if it were not for his unparalleled persistence and motivation as my
advisor. I can only hope that as I move forward in my life I will have as much love
and passion for organic chemistry as Dr. Scheerer displays everyday working in
the lab. I would also like to express my deepest appreciation to Dr. Elizabeth
Harbron and Dr. Robert Hinkle for sitting on my thesis defense committee and
providing me with their thoughtful and meaningful criticism of this thesis.
I would also like to thank the many members of the Scheerer lab who have made
my time working in lab enjoyable and productive. In particular, I would like to
thank Adam Wang. Acting as his mentor this past year in lab has provided me
with an unparalleled opportunity to learn the fundamentals of teaching. He has
displayed a great work ethic and an ability to absorb and retain the many skills
and techniques which I have done my best to help him learn and understand. I
would also like to thank the many friends I have managed to acquire during my
time here at William & Mary. In particular, I am very appreciative to my group of
master’s student friends: James, Jenna, Shelle, and Matt. Their friendship has
made my time both in and out of lab amazing, and I can truly say that we will
remain friends for many years to come no matter where our next roads may lead.
I would like to thank my parents David and Karen for their unyielding support
throughout my entire life. They have provided me with more love and
opportunities than I can even imagine. Finally, I would like to thank my fiancé
Peter Booth for his love and affection. He gives me the motivation and support to
get up and to go to work every morning and provides an even better reason to
want to come home at the end of the day. I cannot wait to move with him to Ann
Arbor, Michigan and begin the next chapter of our life together.

ii

This thesis is dedicated to my parents Karen and David and my fiancé Peter
Booth. Without their unending support and love, I would not be where I am today.

iii

Chapter 1: An Introduction to [2.2.2]-Diazabicyclic Alkaloids
Overview of [2.2.2]-diazabicylic Alkaloids
Prenylated indole alkaloids containing a bicyclo[2.2.2]-diazaoctane core were first
isolated in the late 1960’s as secondary metabolites from a number of fungal species.1,2,3,4
The family now contains more than 10 different subgroups comprised of over 100 distinct
members (Scheme 1). Many [2.2.2]-diazabicyclic alkaloids possess desirable biological
activities including calmodulin inhibition, cytotoxicity, anthelmintic, and neuroprotection
making them ideal natural product targets for synthetic chemists.1,5,6 The unique structure
and diverse range of biological activities of [2.2.2]-diazabicyclic alkaloids have made them
the subject of intense investigation since their discovery.7

Scheme 1. Examples of various [2.2.2]-diazabicyclic natural products.

Structurally, members of the family are formed of three parts: the eponymous
bicyclo[2.2.2]-diazaoctane core, an amino acid derived cyclic portion, and a tryptophan
moiety.1,7 The core piece is quite standard among most members of the family with the
only variation being that some members possess a reduced monoketopiperazine core
instead of the more common diketopiperazine form. The cyclic portion is most commonly
a five-membered proline derived ring, however the marcfortine family of natural products
1

(including chrysogenamide A) possess a unique six-membered ring derived from pipecolic
acid. Finally, the pendant tryptophan moiety is where the most variety exists between
family members. Some contain halogenation (e.g. malbrancheamide B), while others have
various prenyl derived substitution (e.g. stephacidin A and veriscolamide B).
Members of the family can be further classified by the relative stereochemistry at
C19 (brevianamide numbering) on the core. Namely, the hydrogen at this position possess
either a syn- or anti-configuration with respect to the secondary lactam bridge.1 The less
common anti-configuration has only been found in the breavianamide family and two other
metabolites: chrysogenamide A and veriscolamide B.1
Isolation and Biosynthesis
The breavianamides were isolated by Birch and Wright in 1969 from Penicillium
brevicopactum and were the first family of fungal secondary metabolites found to contain
the bicyclo[2.2.2]-diazaoctane core.2 Since that first isolation, over 100 distinct alkaloids
have been isolated containing the bicyclo[2.2.2]-diazaoctane core. Interestingly, it has
been discovered that different fungal species can produce different enantiomers of the
metabolites. For example, the marine fungus Aspergillus sp. MF297-2 produces (-)stephacidin A, whereas the terrestrial fungus Aspergillus versicolor produces its
enantiomer (+)-stephacidin A.1, 8, 9, 10
After isolating the breavianamides in 1969, Birch and co-workers conducting
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C-

labeled incorporation studies to investigate the biosynthetic pathways of the
brevianamides.1,4 These studies initially revealed that brevianamide A is derived from Lproline and L-tryptophan residues. Further analysis showed that the residues undergo a
condensation to form cyclo-L-Trp-L-Pro which they called brevianamide F followed by a
C2 reverse prenylation of the indole to give deoxybrevianamide E. Birch proposed that a
subsequent oxidation and cyclization of deoxybrevianamide E would lead to brevianamide
B. Using similar tracer incorporation studies, Williams and co-workers found that
2

deoxybrevianamide E does in fact undergo a stereosective indole oxidation.9,10 This is
followed by another 2e- oxidation, intramolecular Diels-Alder (IMDA), and pinacol
rearrangement to give brevianamide. Despite extensive efforts, the exact order of last
three steps in the biosynthetic pathway has not been revealed.

Scheme 2. Proposed biosynthetic pathway for the notoamides and stephacidins.

Significant effort has been devoted by Williams and Sherman to investigating the
biosynthetic pathways of the notoamides and stephacidins in different fungal species
because of the discovery that different species produce different enantiomers.9,10 Genome
sequencing and bioinformatic mining studies by Sherman isolated several gene clusters
in the biosynthesis of the notoamides and stephacidins.9 Combined with biochemical
studies, this enabled the development of an extensive biosynthetic pathway (Scheme 2).10
They confirmed that the unique enantioselectivity observed in different fungal species was
derived from an enantioselective IMDA reaction of an achiral pyrazinone precursor
(Scheme 3).1 Although, the so-called Diels-Alderase enzyme has not been isolated all
other evidence still supports that the entioselectivity is derived from a selective Diels-Alder
reaction.
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Scheme 3. Enantioselctive IMDA in the biosynthesis of stephacidin A.

Synthetic Strategies Towards the Bicyclo[2.2.2]-diazaoctane Core
Several synthetic strategies have been developed to make the bicyclo[2.2.2]diazaoctane core en route to various natural products in the family including: (1)
intramolecular SN2’ cyclization11,12 (2) biomimetic intramolecular Diels-Alder (IMDA)
reaction7,13, (3) radical cyclization14, (4) oxidative enolate coupling15, (5) cationic
cyclization cascade16,17,18, (6) Dieckmann condensation19, and (7) oxidative aza-Prins
cyclization20.
The intramolecular SN2’ cyclization was developed by the Williams research group
as a key method for the synthesis of a number of different prenylated indole alkaloid. 7 Its
first use in the synthesis of a [2.2.2]-diazabicyclic alkaloid came during the Williams
groups’ synthesis of brevianamide B and again during their subsequent syntheses of
paraherquamide B and stephacidin A (Scheme 4).11,12 During the synthesis of
brevianamide B, synthesis of the key allylic chloride SN2’ cyclization precursor 2 from
known allylated proline derivative 1 was followed by reaction with NaH in hot benzene with
18-crown-6 added provided the desired epimer 3 of the [2.2.2]-diazabicylic core with anti-

4

stereochemistry at C19 in a 4:1 ratio with the undesired syn-C19 epimer. 3 was then
carried forward in 4 steps to give brevianamide B. A similar allylic chloride precursor 4 was
used in the synthesis of paraherquamide B. Reaction of 4 with NaH in hot benzene without
addition of 18-crown-6 provided the core scaffold 5 with exclusively syn-C19
stereochemistry, as desired. 5 was then moved forward to paraherquamide B in 8
additional steps.

Scheme 4. Williams’ synthesis of brevianamide B and paraherquamide B featuring an intramolecular SN2’
cyclization.

After developing the intramolecular SN2’ cyclization method, the Williams group
moved on to develop the biomimetic IMDA reaction to make the bicyclo[2.2.2]-diazaoctane
core. The IMDA method was first used in the Williams groups’ biomimetic total synthesis
of brevianamide B from biologically isolated epi-deoxybrevianamide E 6 in an effort to
provide evidence for their proposed biosynthesis involving a biogenic Diels-Alder reaction
(Scheme 5).13 Reaction of 6 with Me3OBF4 provided the lactim ether 7 which was then
oxidized to the exocyclic unsaturated Diels-Alder precursor 8 upon reaction with DDQ.
Treatment of 8 with aqueous KOH caused tautomerization to the pyrazinone azadiene 9,
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which immediately underwent an IMDA to give 2:1 mix of diastereomers 10. Brevianamide
B was synthesized by oxidation, pinacol rearrangement, and lactam hydrolysis of the
minor isomer. Since its initial use, the IMDA method has been used in a number of racemic
and asymmetric total syntheses of [2.2.2]-diazabicylic natural products.7

Scheme 5. Williams’ synthesis of brevianamide B featuring a biomimetic IMDA reaction.

While the biomimetic IMDA reaction developed by Williams and co-workers has
arguably been the most widely used method for synthesis of the bicyclo[2.2.2]diazaoctane
core, a number of other methods to synthesize the core have been developed in
subsequent years.
In their pursuit of stephacidin A, Myers and co-workers used a radical iminium
cyclization to form the [2.2.2]-diazabicyclic core.14 Baran and co-workers developed an
oxidative enolate coupling promoted by Fe(acac)3 to form the core during their synthesis
of stephacidin A (Scheme 6).15 The cationic cyclization cascade was developed by
Simpkins and co-workers in their asymmetric synthesis of (–)-malbrancheamide B.16 Their
key precursor was a proline DKP with pendent indole and prenyl groups. Treatment of the
precursor with TMS-OTf initially cleaves the Boc group from the indole nitrogen and
subsequently promotes cyclization of the indole onto the prenyl group which then cyclizes
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onto the DKP ring to establish both the bicyclo[2.2.2]-diazaoctane core and cyclohexene
ring adjacent to the indole nucleus.

Scheme 6. Asymmetric synthesis of stephacidin A by Baran and co-workers featuring an oxidative enolate
coupling.

More recently, the Sarpong group published their asymmetric synthesis of (+)stephacidin A (Scheme 7).19 Starting from precursor 11, the [2.2.2]-diazabicylic core 12
was established from a Dieckmann condensation of the isocyanate-enolate intermediate
13 formed from treatment of 11 with Dess-Martin periodinane followed by reaction with
K2CO3. Wolff-Kishner reduction of the ketone group followed by reduction of the
chromanone carbonyl group afforded (+)-stephacidin A. Additionally, they demonstrated
that treatment of (+)-stephacidin A with excess MnO2 gave (+)-notoamide I which
possesses a carbonyl at C10, adjacent to the [2.2.2]diazabicylic core. In 2016, notoamide
I was the target of a synthesis by Sun, Li, and co-workers who established the core through
an oxidative aza-Prins cyclization.20 This synthesis will be discussed in more detail in
chapter 2 of this thesis.
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Scheme 7. Synthesis of (+)-stephacidin A and (+)-notoamide I by Sarpong and co-workers featuring

Conclusions
[2.2.2]-Diazabicyclic alkaloids represent a distinct class of natural products with a
unique structural motif and diverse biological activities. Since the initial isolation of the
brevianamides by Birch and Wright in 1969, a wide array of synthetic methods have been
developed for the synthesis of the bicyclo[2.2.2]-diazaoctane core. Much room still exists
to explore the use of Diels-Alder reactions to establish the [2.2.2]-diazabicyclic core and
improve the stereoselectivity of such reactions.
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Chapter 2: Diels-Alder Reactions of a C2-Carboxy Pyrazinone
Introduction
Between 2008 and 2010, Tsukamoto and co-workers published several articles on
the isolation of several new prenylated indole alkaloids from the marine derived fungus
Aspergillus sp. that possessed unique oxygenation at C10 (Scheme 1).21,22 These
metabolites are members of the notoamide family of [2.2.2]-diazabicylic alkaloids and are
related to the previously isolated alkaloid stephacidin A. It was later shown that
notoamides F-H and notoamide R are downstream oxygenated metabolites of stephacidin
A.1 For example, notoamides R possess a hydroxyl group at C10 and notoamide I is
further oxidized possessing a carbonyl at C10. Alternatively, Stephacidin A and
avrainvillamide are less oxidized at C10. Bioactivity assays conducted on the newly
isolated metabolites showed that notoamide I is cytotoxic towards HeLa cells with an IC50
value of 21 μg/mL.21 While this value is not as impressive as those of stephacidin A or the
structurally related avrainvillamide which both possess impressive IC50 values of 1 μM and
60 nM, respectively

Scheme 1. Examples of [2.2.2]-diazabicyclic alkaloids with oxidation at C10.

In 2016, Sun, Li, and co-workers published their synthesis of notoamides F, I, and
R as well as the related spirocyclized alkaloid sclerotiamide (Scheme 2).20 To date, it
9

remains the only published method for synthesis of these oxidized [2.2.2]-diazabicyclic
alkaloids. Their retrosynthetic plan was targeted at synthesizing notoamide I as it is the
most oxidized at C10. They comment that their initial efforts to follow a similar pathway to
the tandem radical cyclization methods developed by Simpkins and co-workers were met
without success due to the unique C10 oxidation. This led them to develop a new method
whereby the [2.2.2]-diazabicyclic core 2 is formed through an oxidative aza-Prins
cyclization of DKP 1. The indole moiety was introduced using a Grignard reaction to give
3. Cobalt-catalyzed radical cyclization of the indole onto the pendant isoprenyl group
establishes the main scaffold followed by deprotection of the benzyl group on the indole
with hydrogenation, copper-catalyzed propargylation and heating to afford notoamide I.
Reduction of notoamide I with DIBAL-H gave (+)-notoamide R as a single stereoisomer
followed by either acid catalyzed methanolysis to give (+)-notoamide F or pinacol
rearrangement to give (-)-sclerotiamide.20

Scheme 2. Sun, Li, and co-workers’ synthesis of notoamides I, R, and F and the spirocyclized sclerotiamide.

Our work related to the synthesis of C10 oxidized [2.2.2]-diazabicyclic alkaloids,
which began before Sun, Li, and co-workers had published their synthesis, was focused
10

on establishing the [2.2.2]-diazabicyclic core through the IMDA cyclization of a C2-carboxy
DKP-azadiene with a pendant reverse prenyl dienophile. Our first goal was to develop a
reliable synthetic path to the C2-carboxy DKP-azadiene IMDA precursor in order to
evaluate if there is any inherent diastereoselectivity of the Diels-Alder when the C2carbonyl is present. After studying the intrinsic reactivity and selectivity of the C2-carboxy
substrates, we hoped that having a carbonyl α to the DKP-azadiene would provide a
handle to introduce some form of enantioselective catalysis to the Diels-Alder. In
particular, Johnston and co-workers showed that their bis(amidine) (BAM) catalytic system
was capable of inducing some control over enantioselectivity during the IMDA step of
Williams’ synthesis of brevianamide (Scheme 3).23 We proposed that the additional C2carboxy group could provide a more attractive alternative binding site for the BAM catalyst.
With these goals in mind, we began work on the synthesis of the desired C2-carboxy DKPazadiene IMDA precursor.

Scheme 3. Enantioselective formation of the bicyclo[2.2.2]diazaoctane core of breavianamide by Johnston
and co-workers using their H,Quin-BAMide catalyst.

Retrosynthetic Plan
Cycloadduct 4 would provide a key scaffold which could be used in the synthesis
of a number of [2.2.2]-diazabicyclic natural products. We proposed that 4 could arise
through the IMDA of pyrazinone (DKP-azadiene) 5. In turn, pyrazinone 5 would be derived
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from an oxidation/elimination cascade of C2-carbomethoxy DKP 6 which is synthesized
from CBZ protected L-proline and dimethylaminomalonate (Scheme 4).24

Scheme 4. Retrosynthetic plan for the synthesis of C10 oxidized cycloadduct 4.

Synthesis of C2-carboxy Diketopiperazines
We started by synthesizing C2-carbomethoxy DKP 7 according to methods
published by Trost and co-workers (Scheme 5).24 The HCl salt of dimethylamino malonate
was coupled with N-Cbz proline to form amide 8. The Cbz group was removed by
hydrogenation followed by heating in methanol to encourage intramolecular cyclization to
C2-carbomethoxy DKP 7. The methyl ester of 7 was then hydrolyzed to carboxylic acid 9
with LiOH, however 9 proved difficult to recover after aqueous work up and extraction
resulting in detrimentally low yields. Instead, the methyl ester of 7 was transesterified to a
benzyl ester in the presence of tributyltin oxide and BnOH. The benzyl group was then
removed by hydrogenation to afford carboxylic acid 9 in good yield without need for an
aqueous workup. The desired reverse prenylated ester 10 was formed through the
coupling of 9 with 2-methyl-3-buten-2-ol in the presence of DCC. We also made allyl ester
11 by transesterification of 7 with allyl alcohol to serve as a model system for developing
an oxidation-elimination method to form the desired pyrazinone.
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Scheme 5. Synthesis of C2-reverse prenyl ester 10 and C2-allyl ester 11.

Oxidation-Elimination of DKP to Pyrazinone Azadiene
Initially, we explored known methods for the oxidation of a DKP to the pyrazinone
tautomer with DDQ (Scheme 6). Williams and co-workers showed that DDQ could
dehydrogenate an alkyl substituted lactim O-Me ether proline DKP 12 to give the exocyclic
unsaturated product 13.25 The exocyclic product could then be easily isomerized in the
presence of NaOH as a base to give pyrazinone 14. Additionally, our lab has shown that
oxidation of DKP 15 with DDQ gives a 85:15 mixture of both the pyrazinone 16 and the
exocyclic unsaturated product 17 without need for a second isomerization step.25 We were
unsure whether oxidation of our model C2-allyl ester DKP with DDQ would directly yield
the desired C2-allyl ester pyrazinone or a cycloadduct resulting from [4+2] cycloaddition
with the pendent allyl group, but we were confident that the reaction would at least provide
the exocyclic unsaturated product if it did not isomerize directly to the pyrazinone.
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Scheme 6. Oxidation of various DKP rings with DDQ to provide pyrazinone azadienes.

The reaction of C2-allyl ester DKP 11 with DDQ in refluxing toluene yielded an
intractable mixture that did not appear to contain any of the possible desired products by
1

H NMR spectroscopic analysis. We surmised that the reaction did not work because DKP

11 lacks the lactim O-Me ether functionality present in both of the example DKP oxidations.
The lactim O-Me ether likely stabilizes the initial exocyclic unsaturated product before
isomerization to the desired pyrazinone. We then attempted the DDQ oxidation again with
BSA added to the reaction as well. Again, the reaction yielded a complex mixture of
products, however, the 1H NMR spectrum of the mixture contained peaks characteristic of
the desired [2.2.2]-diazabicyclic cycloadduct. However, when the mixture was purified by
column chromatography none of the isolated compounds contained these characteristic
cycloadduct peaks. Further reaction attempts again yielded complex mixtures which
appeared to contain the desired cycloadduct, but the supposed cycloadduct was never
isolated upon attempted purification by column chromatography.
We then moved on to other oxidation-elimination methods to make the desired
pyrazinone. First, we attempted to chlorinate the amide nitrogen of DKP 11 by reaction
with t-BuOCl. However, the resulting N-chloro DKP product was not stable at room
temperature or to column chromatography. Instead, we attempted to substitute a tosyl
group onto the nitrogen by stirring with tosyl chloride in the presence of catalytic DMAP
14

according to a procedure published by Olenyuk and co-workers for the N-tosylation of a
similar C2-carboxy DKP.27 After stirring for 3 days at room temperature no desired product
was seen. In the same paper, Olenyuk and co-workers showed that it is possible to
sulfenylate a C2-carboxy DKP at the C2 position using a number of triazole derived
sulfenylation reagents (Scheme 7).26 This type of chemistry could work for our system as
well because it constitutes a formal oxidation of the DKP ring, so we decided to try a
modified sulfenylation reaction on DKP 11 as well as a newly synthesized β-ketone DKP
18.

Scheme 7. Example α-sulfenylation of a C2-carboxy DKP by Olenyuk and co-workers.

α-Sulfenylation of C2-carboxy DKPs
Before we began trying the sulfenylation, we wanted to synthesize a C2-carboxy
DKP with a lactim O-Me ether present to aid in formation of the desired C2-carboxy
pyrazinone during the elimination step. Our lab has previously developed a method for the
synthesis of C2 substituted pyrazinones using aldol chemistry. We extended this
chemistry slightly by doing a Claisen condensation to form the desired C2-carboxy lactim
O-Me ether DKP 18 from the reaction of ester 19 with proline derived DKP 20 (Scheme
8). Interestingly, we found that 18 exists in the enol tautomer indicated by the presence of
a singlet peak in the 1H-NMR far downfield at 13.4 ppm. This likely arises from the fact
that 18 has a β-ketone functionality which is in contrast to the previous C2-carboxy DKP
derivatives which have a β-ester functionality and do not display the downfield proton peak
in their 1H-NMR spectra.

15

Scheme 8. Claisen condensation of ester 19 and DKP 20 to form C2-carboxy DKP 18 followed by αsulfenylation with N-(phenylthio)phthalimide.

Sulfenylation of 18 turned out to be quite easy to accomplish requiring a much less
electrophilic sulfenylation reagent than what was used by Olenyuk and co-workers to
sulfenylate their C2-carboxy ester DKP derivatives. Reaction of 18 with N(phenylthio)phthalimide in the presence of catalytic DBU provided the desired αsulfenylation product 21 without issue. A number of methods to eliminate the sulfenyl
group and produce the desired C2-carboxy pyrazinone substrate were tried including:
heating in base, reaction with various silver(I) salts, and heating in the presence of 2nitrophenol. None of the methods attempted provided the desired pyrazinone product or
any cycloadducts which would result from an IMDA with the pyrazinone. Around the same
time, we found a paper by Van der Eycken and co-workers on the NHC catalyzed
aroylation of 3,5-dichloropyrazinones which could provide the desired C2-carboxy
pyrazinones directly without need for the oxidation-elimination of a C2-carboxy DKP.
NHC Catalyzed Aroylation of 3,5-Dichloropyrazinones as a Method to Synthesize
C2-carboxy Pyrazinones
Diels-Alder and retro Diels-Alder reactions of 3,5-dichloropyrazinones have been
explored previously as methods to access a number of biologically interesting natural
product scaffolds.28 Despite this, there are no examples where a Diels-Alder with 3,5-
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dichloropyrazinone has been used in the synthesis of a [2.2.2]-diazabicyclic alkaloid
natural product. A wide variety of methods have been published for functionalization of the
C3 and C5 positions of 3,5-dihalopyrazinones.27 In particular, Van der Eycken and coworkers developed an N-heterocyclic carbene catalyzed aroylation of the C3 position of
3,5-dichloropyrazinones.28 Their method relies on the umpolung nature of the C3 position
of 3,5-dihalopyrazinones to add in an NHC activated aldehyde to the C3 carbon followed
by elimination of chlorine to reform the pyrazinone aromaticity. We proposed a synthesis
whereby this method could be used with a proline derived 3,5-dichloropyrazinone 22 to
access the C2-carboxy pyrazinone scaffold (Scheme 9). This method would completely
side step the problematic DKP oxidation and elimination steps of our previously proposed
methods to provide the desired azadiene which could then be used in a subsequent DielsAlder to form the [2.2.2]-diazabicyclic core.

Scheme 9. Retrosynthetic plan for synthesis of C2-carboxy pyrazinones from 3,5-dichloropyrazinones.

Synthesis of L-Proline Amino Nitrile
The synthesis of proline derived 3,5-dichloropyrazinone 22 was previously
reported by De Borggraeve and co-workers from the reaction of L-prolinamide with oxalyl
chloride and catalytic DMF.29 Although their procedure involved all commercially available
starting materials, it had a poor yield of only 27% and a long reaction time of heating for 3
days. More commonly, 3,5-dihalopyrazinones are synthesized through the reaction of
substituted amino nitrile salts with oxalyl chloride. The majority of these methods have
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higher reported yields ranging from 40-50%. Therefore, we decided to synthesize 22 from
the corresponding L-proline amino nitrile salt 23 (Scheme 10).

Scheme 10. Synthesis of the HCl salt of L-proline amino nitrile from N-Boc L-proline.

Following known methods, commercially available N-Boc L-proline was stirred with
ethyl chloroformate and NEt3 followed by addition of concentrated ammonium hydroxide
to afford N-Boc L-prolinamide 24 which was then dehydrated in the presence of TFAA and
NEt3 to give N-Boc L-proline amino nitrile 25. Boc deprotection of 25 with 4N HCl in
dioxane yielded the HCl salt of L-proline amino nitrile 23.30,31
Synthesis of Proline Derived 3,5-Dichloropyrazinone
With the amino nitrile precursor in hand, we began synthesis of the desired 3,5dichloropyrazinone 22. The first reaction of L-proline amino nitrile HCl salt 23 with oxalyl
chloride resulted in a poor isolated yield (22% after purification) of 22. The HCl salt of 23
was quite gummy and wet making it difficult to properly measure and add to the reaction.
Coupled with its poor solubility in the reaction solvent, chlorobenzene, we surmised that
this was likely the cause of the poor yield. Instead of using the HCl salt of 23, we made
the TFA salt which could be recrystallized from ether to provide a much drier solid material
that was easier to work with.32 After a number of trials (Table 1), varying reaction
temperature and adding a catalytic amount of DMF one hour into the reaction, we were
able to raise the isolated yield of 22 to a reasonable 45% which was comparable with other
reported literature yields for the synthesis of 3,5-dichloropyrazinones.
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Table 1. Trials for the cyclization of the TFA salt of 23 to 3,5-dichloropyrazinone 22.

NHC Catalyzed Aroylation
Following Van der Eycken and co-workers’ procedure, 3,5 dichloropyrazinone 22
was reacted with p-anisaldehyde in the presence of NHC catalyst 24 and NaH to give C2carboxy pyrazinone 25 for studying intermolecular Diels-Alder reactions. 22 was also
reacted with aryl aldehyde 26 in the presence of NaH and 24 to give pyrazinone 27 for
use in studying intramolecular Diels-Alder reactions (Scheme 11).

Scheme 11. NHC catalyzed aroylation of 22 to give C2-carboxy pyrazinones.
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We set about studying the relative propensity of pyrazinones 25 and 27 to undergo
both intermolecular and intramolecular [4+2] cyclizations. 25 was reacted with a large
excess of styrene to give a 3:2 mixture of diastereomers 28 and 29. This reactivity was
not highly different than previously observed Diels-Alder reactions of pyrazinones in terms
of selectivity. We attempted the reaction several more times with a number of Lewis acid
additives, but none of the reactions provided any products resulting from cycloaddition
(Table 2). Pyrazinone 27 was quite stable and did not readily undergo intramolecular
cycloaddition at ambient temperatures. Heating 27 in refluxing toluene for 72 hours was
also incapable of initiating cycloaddition. We hope to increase reactivity by converting the
chlorine at C5 on the pyrazinone to a methoxy group with treatment of NaOMe to give
pyrazinone 30. However again, heating of 30 in refluxing toluene provided no desired
cycloaddition products (Scheme 12).
Table 2. Intermolecular Diels-Alder reactions of pyrazinone 25 with styrene.
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Scheme 12. Attempted IMDA reactions of C2-carboxy pyrazinones 27 and 30.

Conclusions
The intermolecular Diels-Alder with a C2-carboxy pyrazinone did not provide any
increase to the selectivity of the Diels-Alder reaction when compared to reactions with
substrates lacking oxidation at C2. Furthermore, attempts to increase selectivity with the
addition of various Lewis acids was met without success. The intramolecular Diels-Alder
reaction was also unsuccessful. Heating at high temperatures failed to induce
cycloaddition of pyrazinones 27 and 30, when similar compounds without the additional
oxidation adjacent to the DKP ring are known to undergo cycloaddition at even ambient
temperatures. These results coupled with the poor yields of reactions used to synthesized
the C2-carboxy pyrazinone precursors led us to believe that further investigation would
not provide meaningful results.
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Chapter 3: Intermolecular Diels-Alder of a Pyrazinone with Symmetric Dienophiles
Introduction
The use of an intermolecular Diels-Alder cycloaddition to form the bicyclo[2.2.2]diazaoctane core was explored previously by our lab.1 The [4+2] cycloaddition of a proline
derived pyrazinone (azadiene) 1 with both achiral and chiral acrylate dienophiles permits
rapid assembly of the [2.2.2]-diazabicylic core in a stereoselective fashion (Scheme 1).33
The thermal [4+2] cycloaddition of ethyl acrylate and 1 resulted in a 3:1:1 mixture of regioand stereoisomers with the major product 2 corresponding to cycloaddition from the endo
transition state with the ethyl ester positioned distal to the indole nucleus of the
pyrazinone. Furthermore, the reaction of 1 with a chiral dienophile, (+)-acryloyl camphor
sultam, proved capable of inducing asymmetry in the cycloaddition providing a single
diastereomer 3 (dr > 19:1) corresponding to cycloaddition from the endo transition state
with the amide positioned distal to the indole of the pyrazinone. Both cycloadditions
provide products with regiochemistry that does not easily permit extrapolation to natural
products in the [2.2.2]-diazabicylic alkaloid family.

Scheme 1. Racemic and enantio-enriched Diels-Alder cycloadditions of pyrazinone 1 with acrylate
dienophiles.
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In order to obtain the desired regioisomer with the carboxy group proximal to the
indole nucleus, cycloaddition of 1 with methyl 2-nitroacrylate was performed. In the event,
cycloaddition of 1 with the nitroacrylate dienophile provided the two regioisomeric
products, 4 and 5, in a 4:1 ratio with the desired product being the major isomer (Scheme
2). Both regioisomers were derived from cycloadditions where the nitro group is positioned
endo in the cycloaddition transition state. However, the two regioisomers proved difficult
to separate by column chromatography, and attempts to remove the nitro group resulted
in elimination rather than direct reduction. Instead, it became more operationally simple to
induce elimination of the nitro group with DBU and separate the two resulting unsaturated
ester products by column chromatography. Attempted stereoselective hydrogenation of 5
with various catalysts such as Crabtree’s catalyst and Striker’s reagent under various
reaction conditions gave limited success. Hydrogenation of unsaturated ester 6 with Pd/C
resulted in a 1:1 mix of anti- and syn-fused C19 isomers, 7 and 8. The two isomers were
separated and carried forward in two separate routes to intercept known intermediates in
the Williams synthesis of brevianamide B (anti-fused isomer 7) and the Baran synthesis
of premalbrancheamide (syn-fused isomer 8).
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Scheme 2. Diels-Alder cycloaddition of pyrazinone 1 with 2-nitroacrylate to intercept known
intermediates from two separate syntheses of bicyclo[2.2.2]diazaoctane alkaloids by Baran and
Williams.

Overall, the route provided efficient entry to the bicyclo[2.2.2]diazaoctane core
(four to five steps from proline methyl ester) and gave useful insight into the intermolecular
Diels-Alder of pyrazinone 1 with a number of acrylate derived dienophiles. It demonstrated
that the [4+2] cycloaddition is most favorable with electron deficient substrates. The more
electron withdrawing substituent on the dienophile adds distal to the indole nucleus in an
endo fashion. This was exploited in the cycloaddition with nitroacrylate to obtain the
desired regeiochemistry with the methyl ester positioned proximal to the indole nucleus.
The route has a few limitations. Mainly, the Diels-Alder is not particularly selective
providing a 4:1 mix of products, the nitroacrylate dienophile is not commercially available
and must be synthesized in 3 steps from methyl acrylate, and the hydrogenation of the
unsaturated methyl ester 6 is entirely unselective affording a 1:1 mix of anti- and syn-fused
products. With these limitations in mind, we sought to explore the intermolecular DielsAlder cycloadditions of commercially available symmetric dienophiles with pyrazinone 1
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with the goal of developing separate synthetic routes to the anti- and syn-fused methyl
ester products, 7 and 8.
Developing Separate Routes to the syn- and anti-C19 Isomers
When thinking about developing separate synthetic routes to the anti- and synC19 isomer, we proposed that the use of symmetric electron deficient dienophiles would
limit the number of possible regio- and stereoisomeric products of the Diels-Alder
reactions when compared to the acrylate derived dienophiles. We envisioned that the synC19 isomer could be derived from the Diels-Alder reaction of pyrazinone 1 with dimethyl
fumarate based on the selectivity of the nitroacrylate reactions. Selective hydrolysis of the
methyl ester at C18 followed by excision of the resulting carboxy group using radical
decarboxylation would give the syn methyl ester product 8. Similarly, we proposed that
the [4+2] cycloaddition of 1 with maleic anhydride would likely give the endo cycloadduct
as the major product which would establish the desired anti-C19 stereochemistry. The
desired anti methyl ester product 7 would then be achieved through selective anhydride
opening and excision of the C18 carboxy group (Scheme 3).

Scheme 3. Proposed synthetic routes to anti- and syn-C19 isomers.
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Intermolecular Diels-Alder with Dimethyl Fumarate
The [4+2] cycloaddition of 1 with dimethyl fumarate proceeded readily at room
temperature and yielded a single diastereomer 9 (dr > 20:1 as judged by 1H NMR of the
unpurified reaction) (Scheme 4). The unpurified reaction mixture was quite clean,
containing only desired product and excess dimethyl fumarate. Using NOESY NMR
spectroscopy, we initially determined that 9 possessed the syn-fused stereochemistry at
C19. This result was in agreement with previous results wherein the group at C18 is
oriented endo in the Diels-Alder transition state to push it as far from the pendant indole
as possible. Surprisingly, the stereoselectivity for the major product with dimethyl fumarate
was much higher than with either of the two acrylate derived dienophiles (i.e. dr > 20:1
with dimethyl fumarate vs dr = 4:1 with nitroacrylate). The absolute stereochemistry of 9
was confirmed from an X-ray crystal structure of the lactam product 10 obtained from
hydrolysis of 9 with TsOH and H2O to give the open chain tautomer of the lactim O-methyl
ether followed by recyclization to the lactam.

Scheme 4. [4+2] cycloaddition of pyrazinone 1 with dimethyl fumarate followed by hydrolysis of
lactim O-methyl ether 9 to give lactam cycloadduct 10.
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Selective Hydrolysis of the Dimethyl Fumarate Cycloadduct
With structure of the dimethyl fumarate cycloadduct determined by X-ray
crystallography, we began work on the selective hydrolysis of the methyl ester at C18 to
provide a carboxylic acid which could be removed by radical decarboxylation (Scheme 5).
It was shown previously that monohydrolysis of bicyclo[2.2.1]heptane-2,3-dicarboxylate
derivatives with LiOH or KOH is highly selective for the exo ester.34 We found that
hydrolysis of 10 with LiOH·H2O (1.05 equivalents) stirring at 0 °C for 18 hours gave only
the bishydrolysis product and unreacted starting material. We then turned to tin mediated
transesterification and hydrolysis methods with the hope that the bulkier tin reagents would
be able to provide some selectivity.
First, we attempted tin mediated transesterification, pioneered by Otera, by stirring
10 and BnOH in the presence of catalytic bis(tri-n-butyl tin) oxide in refluxing toluene for
24 hours.35 The reaction afforded only the doubly transesterified product with no apparent
selectivity. Nicolaou and co-workers showed that selective hydrolysis of a wide variety of
methyl esters could be achieved using trimethyltin hydroxide.36 Reaction of 10 with
trimethyltin hydroxide in refluxing 1,2-dichloroethane provided a 1:1 mix of monohydrolysis
products with no apparent selectivity. While the methods we attempted did not appear to
provide selective hydrolysis, it is by no means exhaustive and there are certainly other
methods that could provide selectivity, but we decided to focus more heavily on the
reaction of 1 with maleic anhydride.
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Scheme 5. Attempted methods for selective monohydrolysis and transesterification of dimethyl
fumarate cycloadduct 10.

Intermolecular Diels-Alder with Maleic Anhydride
The intermolecular Diels-Alder of maleic anhydride with pyrazinone 1 could provide
only two possible diastereomeric products. We surmised that the major product would
likely be the product derived from the endo transition state providing the desired anit-fused
stereochemistry at C19. When conducted, the [4+2] cycloaddition of maleic anhydride with
pyrazinone 1 proceeded smoothly at room temperature yielding an 8:1 (endo:exo) mix of
cycloadducts 11 and 12 as determined by 1H-NMR analysis of the unpurified reaction
mixture (Scheme 6). Cooling the reaction to -20 °C did not provide any change in
selectivity, however heating the reaction at 50 °C decreased selectivity from 8:1 to 6:1
(endo:exo). The two isomers were easily separated by column chromatography providing
the desired endo isomer 11. To obtain the desired methyl ester product 7, we needed to
selectively open the anhydride cycloadduct with an appropriate nucleophile and
selectively excise the carboxyl group at C18.
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Scheme 6. Diels-Alder cycloaddition of pyrazinone 1 with maleic anhydride.

Selective Opening of Malic Anhydride Cycloadduct
In order to determine if there was any inherent selectivity for opening the anhydride
of the cycloadduct, we reacted cycloadduct 11 with methanol in the presence of DMAP.
The reaction provided a 1:6 mix of mono-methyl ester products. Upon purification of the
reaction mixture by flash column chromatography, both products degraded and were not
recovered after being loaded onto the column. We suspected that the acid sensitive lactim
O-methyl ether functionality was being hydrolyzed by the carboxylic acid formed during
the anhydride opening. The lactim O-methyl ether hydrolysis product would be highly polar
because of its Zwitter-ionic nature and not likely to come off the column with the conditions
used. We overcame this problem by doing an in situ protection of the carboxylic acid with
benzyl bromide after opening the anhydride cycloadduct 11 with methanol. The resulting
products were then stable to column chromatography and were isolated in a 1:9 mix
(Scheme 7).
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Scheme 7. Selective nucleophilic opening of maleic anhydride cycloadduct 11 followed by in situ
protection of the resulting carboxylic acid.

Using 2D-NMR we were able to determine that the major product had the methyl
ester at C18 and the benzyl ester at C19 resulting from selective nucleophilic attack of the
methanol at the anhydride carbonyl distal to the indole moiety. This provided the wrong
regiochemistry for the resulting esters, as we wanted the methyl ester at C19 and the
benzyl ester at C18. To obtain the desired regiochemistry, we instead opened the
anhydride cycloadduct 11 with benzyl alcohol followed by in situ protection of the resulting
carboxylic acid with methyl iodide affording a 6:1 mix of the desired and undesired
regioisomers, 13 and 14. Unfortunately, the sequence was plagued by a poor overall yield
(< 30% over the two steps), so we sought to improve the yield by changing the electrophilic
methylation reagent. Instead of methyl iodide we used TMS diazaomethane as the
methylation reagent. The reaction still provided the desired product, but the yield of 26%
over two steps was still quiet poor. Opening the anhydride at –78 °C with the more
nucleophilic lithiated benzyl alcohol provided the desired product with an improved yield
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of 49% and slightly improved selectivity of 7:1 for the desired regioisomer 13. Hydrolysis
of the lactim O-methyl ether functionality of 13 with TsOH·H2O and recyclization provided
lactam 15 in high yield. Simple deprotection of the benzyl ester at C18 by hydrogenation
provided the carboxylic acid precursor 16 necessary for radical decarboxylation (Scheme
8).

Scheme 8. Conversion of the lactim O-methyl ether 13 to lactam 15 by hydrolysis and recyclization
followed by deprotection of the benzyl ester at C18 to give carboxylic acid 16.

Radical Decarboxylation to Obtain the Anti-fused Methyl Ester
Since Barton and co-workers published their seminal works on the eponymous
Barton decarboxylation reaction in 1962 and 1980, methods for radical decarboxylation
have been both widely used and improved upon to convert carboxylic acids into many
other functional groups.37,38,39 The original Barton decarboxylation protocol involved
converting the carboxylic acid into an acid chloride followed by addition of 2mercaptopyridine N-oxide to form a thiohydroxamate ester. The N-O bond of the
thiohydroxamate ester is prone to homolytic bond cleavage. When heated in the presence
of the radical initiator AIBN and a hydrogen donor such as tri-n-butyltin hydride, the ester
undergoes radical bond cleavage, decarboxylation, and a radical hydride transfer to give
the decarboxylated hydrocarbon product.
Modern methods have replaced the highly toxic tri-n-butyltin hydride with less toxic
reductive hydride donors such as t-butyl thiol. In the early 1980s, Okada and co-workers
published several articles demonstrating that N-hydroxy phthalimide derived esters were
also capable of undergoing homolytic bond cleavage and decarboxylation to form alkyl
radicals which they then reacted with hydride donors to form hydrocarbons or diphenyl
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diselenide to form alkyl selenides.40,41 They also demonstrated that homolytic N-O bond
cleavage of the phthalimodyl esters could be initiated using a variety of methods including:
heating in the presence of AIBN (1) and photocatalytic initiation with both organic and
inorganic photocatalysts (2). More recently, Nicewicz and co-workers have developed a
catalytic hydrodecarboxylation method which uses an organic photocatalyst to directly
convert carboxylic acids to hydrocarbons.42
While attempting the Barton decarboxylation method on a model system derived
from the opening of 1,2-cyclohexane dicarboxylic anhydride, we found that the Barton
ester could be formed in good yields by doing an EDC coupling of the carboxylic acid
precursor with 2-mercaptopyrine N-oxide. We also discovered that the resulting Barton
ester was light sensitive, and the use of column chromatography for purification resulted
in diminished yield of pure product and isolation of an undesired by-product resulting from
decarboxylation of the ester and recombination of the resulting alkyl radical with the
thiopyridine radical produced from the initial N-O bond cleavage. Therefore, when working
with our actual decarboxylation substrate 16, we decided to attempt making both the
thiohydroxamate and phthalimidoyl esters for decarboxylation. We surmised that the
phthalimidoyl ester would be more stable to light and heat than the thiohydroxamate ester,
and could therefore likely be purified and isolated by column chromatography without
issue.
As predicted, the EDC coupling of carboxylic acid 16 with 2-mercaptopyridine Noxide yielded a mix of products that was light sensitive and not stable to purification by
column chromatography. On the other hand, the coupling of acid 16 with N-hydroxy
phthalimide provided the desired ester 17 in good yield, and the product was easily purified
to remove excess N-hydroxy phthalimide and EDC related compounds. Following the
protocol from Okada and co-workers, we first attempted a photocatalyzed decarboxylation
by stirring ester 17 under blue LEDs in the presence of a Hantzsch ester (diethyl-1,432

dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate), t-BuSH, 10 mol% of Ru(bpy)3Cl2·6H2O
using a 7:3 mix of THF:H2O as the solvent. After stirring at room temperature for 24 hours,
the reaction resulted in only recovered starting material and a by-product resulting from
hydrolysis of the ester back to the carboxylic acid in the presence of water. The
photocatalyzed decarboxylation was attempted once more using CH3CN as a solvent
instead of a THF:H2O mixture, but it resulted in a mixture of products which did not appear
to contain the desired methyl ester product. Clean decarboxylation of ester 17 to afford
the desired anti-fused methyl ester 18 was finally achieved by heating in the presence of
AIBN, Hantzsch ester, and t-BuSH using CH3CN as a solvent (Scheme 9).

Scheme 9. EDC coupling of carboxylic acid 16 with N-hydroxy phthalimide to form phthalimidoyl ester 17,
followed by radical decarboxylation to afford the desired anti-fused C19 methyl ester 18.

Conclusions
The structure of 18 was confirmed by making 18 using the methods described in
the previous synthesis using nitroacrylate as the dienophile (i.e., hydrogenation of the
unsaturated methyl ester cycloadduct followed by lactam hydrolysis of the two isomer and
separation by column chromatography).33 Our overall route to the anti-C19 stereoisomer
of methyl ester [2.2.2]-diazabicyclic alkaloid 18 takes 6 steps from proline derived DKP 1
with an overall yield of 12%. 18 is a known compound that is 3 steps from an intermediate
in the Williams’ synthesis of brevianamide B constituting a 15 step formal synthesis
(longest linear route). The route improves upon the previous synthesis by our group, as it
provides only a single stereoisomer at C19 instead of a 1:1 mix of anti:syn stereoisomers.
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Additionally, the starting maleic anhydride dienophile is commercially available and does
not have to synthesized, unlike the nitroacrylate dienophile which requires 3 steps that are
not particularly easy to accomplish. Although, the yields of the two routes are comparable
the new route is an improvement in overall steps and the fact that it uses a commercially
available dienophile.
Experimental
General Information
Unless otherwise noted, all reactions were carried out in flame-dried or oven-dried
glassware under an atmosphere of nitrogen with magnetic stirring. THF, toluene, and
acetonitrile were degassed with argon and dried by passage through a column of
molecular sieves and a bed of activated alumina. Dichloromethane was distilled from CaH2
prior to use. All reagents were used as received unless otherwise noted. Flash column
chromatography was performed using SiliCycle siliaflash P60 silica gel (230-400 mesh).
Analytical thin layer chromatography was performed on SiliCycle 60Å glass plates.
Visualization was accomplished with UV light, ceric ammonium molybdate, potassium
permanganate, or ninhydrin, followed by heating. Film infrared spectra were recorded
using a Digilab FTS 7000 FTIR spectrophotometer. 1H NMR spectra were recorded on an
A400b Agilent DD2 NMR (400 MHz) spectrometer and are reported in ppm using solvent
as an internal standard (CDCl3 at 7.26 ppm) or TMS (0.00 ppm). Proton-decoupled

13

C

NMR spectra were recorded on an A400b Agilent DD2 NMR (100 MHz) spectrometer and
are reported in ppm using solvent as an internal standard (CDCl3 at 77.00 ppm). All
compounds were judged to be homogeneous (>95% purity) by 1H and

13

C NMR

spectroscopy. Mass spectra data analysis was obtained through positive electrospray
ionization (w/ NaCl) on a Bruker 12 Tesla APEX-Qe FTICR-MS with an Apollo II ion
source.
*All compounds listed were isolated as racemic mixtures.
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Experimental Procedures

Dimethyl (6R*,7R*,8R*,8aR*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-9methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-(azenometheno)indolizine-7,8dicarboxylate. (9)
A dry flask was charged with pyrazinone 1 (200 mg, 0.51 mmol) and dimethyl fumarate
(146 mg, 1.01 mmol). The reaction flask was then flushed with N2 gas for 10 min before
toluene (5 mL) was added and the vessel evacuated to 40 torr for 5 min and backfilled
with N2 gas. The reaction flask was covered in foil to keep out ambient light, and the
reaction stirred at rt for 16 h. The solution was concentrated in vacuo to afford a yellow
oil, which contained a single cycloadduct 9 (dr > 20:1 as judged by 1H NMR of the
unpurified reaction mixture) and excess dimethyl fumarate. The resulting residue was
purified by flash column chromatography on silica gel (gradient elution: 20% → 100%
EtOAc in hexanes) to afford cycloadduct 9 as a yellow oil (240 mg, 88% yield): TLC (60%
EtOAc in hexanes), Rf: 0.28 (UV, CAM); IR (film, cm-1) 2986, 2948, 1729, 1685, 1638,
1450, 1367, 1308, 1256, 1155, 1082, 1015, 745; 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=
8.3 Hz, 1H), 7.77 (dd, J= 7 Hz, 0.9 Hz, 1H), 7.74 (s, 1H), 7.27 (td, J= 7.5 Hz, 1.2 Hz, 1H),
7.19 (td, J= 7.8 Hz, 1.2 Hz, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 3.64 (s, 3H), 3.56 (m, 1H), 3.51
(m, 1H), 3.49 (d, J= 15.2 Hz, 1H), 3.26 (d, J= 15.2 Hz, 1H), 3.16 (d, J= 5.5 Hz, 1H), 3.03
(d, J= 5.5 Hz, 1H), 2.62 (m, 1H), 2.05 (m, 2H), 1.95 (m, 1H), 1.66 (s, 9H);
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C NMR (400

MHz, CDCl3) δ 171.5, 170.8, 170.6, 169.5, 149.9, 132.2, 125.6, 123.8, 121.8, 120.8, 116.0,
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114.8, 83.1, 68.5, 64.8, 54.9, 52.9, 52.5, 50.0, 43.5, 28.2, 28.1, 28.1, 27.1, 24.5; MASS
SPEC SAMPLE NEEDS TO BE SUBMITTED.

Dimethyl (6S*,7R*,8R*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-5,9dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-7,8-dicarboxylate. (10)
A dry flask was charged with cycloadduct 9 (275 mg, 0.51 mmol) and flushed with N2 gas
for 10 min, dissolved in CH2Cl2 (5 mL), and cooled to 0 °C. To the reaction flask was added
pTsOH·H2O (115 mg, 0.61 mmol), and the reaction was stirred for 2 h at 0 °C. The reaction
mixture was diluted with sat’d aq NaHCO3 (10 mL) and extracted with CH2Cl2 (4 X 10 mL).
The combined organic layers were washed with sat’d aq NaCl (50 mL), dried with
anhydrous Na2SO4, filtered, and concentrated in vacuo. The resulting product was
dissolved in toluene (5 mL) and stirred at 80 °C for 18 h. The solution was concentrated
in vacuo to afford lactam 10 as a white solid. The unpurified reaction mixture was purified
by flash column chromatography on silica gel (gradient elution: 40% → 100% EtOAc in
hexanes) to afford lactam 10 as a pale yellow solid (250 mg, 94% yield): TLC (60% EtOAc
in hexanes) Rf: 0.28 (UV, CAM); m.p. 96.8-97.9 °C; IR (film, cm-1) 3218, 3116, 2953, 2252,
1723, 1695, 1450, 1387, 1361, 1310, 1255, 1205, 1158, 1095, 1003, 911, 852, 724, 645;
H NMR (400 MHz, CDCl3) δ 8.15 (d, J= 8.2 Hz, 1H), 7.73 (s, 1H), 7.60 (d, J= 8.2 Hz, 1H),

1

7.36 (td, J= 8.2 Hz, 1.2 Hz, 1H), 7.28 (td, J= 7.4 Hz, 1.2 Hz, 1H), 5.85 (s, 1H), 3.83 (s, 3H),
3.71 (s, 3H), 3.69 (d, J= 5.3 Hz, 1H), 3.61 (d, J= 15.6 Hz, 1H), 3.61 (m, 1H), 3.58 (m, 1H),
3.44 (d, J= 4.7 Hz, 1H), 3.20 (d, J= 15.7 Hz, 1H), 2.75 (m, 1H), 2.09 (m, 2H), 1.98 (m, 1H),
1.69 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 170.4, 169.8, 169.5, 166.3, 149.4, 135.3, 130.7,
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126.3, 125.0, 123.2, 118.2, 115.6, 112.0, 84.0, 68.0, 62.9, 53.0, 52.9, 52.4, 51.7, 44.3,
28.5, 28.1, 24.3, 24.1; exact mass calc’d for C27H31N3O8Na [M + Na]+ 548.2003, found
548.2006. A single crystal of 10 was obtained by evaporation from Et2O and its structure
was determined by X-Ray crystallographic analysis.

tert-Butyl 3-(((3aS*,4R*,9aR*,9bR*)-10-methoxy-1,3,5-trioxo-1,3,3a,8,9,9bhexahydro-7H-4,9a-(azenometheno)furo[3,4-g]indolizin-4(5H)-yl)methyl)-1H-indole1-carboxylate (11) and Tert-butyl 3-(((3aR*,4R*,9aR*,9bS*)-10-methoxy-1,3,5-trioxo1,3,3a,8,9,9b-hexahydro-7H-4,9a-(azenometheno)furo[3,4-g]indolizin-4(5H)yl)methyl)-1H-indole-1-carboxylate. (12)
A dry flask was charged with pyrazinone 1 (200 mg, 0.51 mmol) and maleic anhydride (98
mg, 1.01 mmol) and flushed with N2 gas for 10 min, cooled to –20 °C, dissolved in toluene
(10 mL), evacuated to 40 torr for 5 min, and backfilled with N2 gas. The reaction flask was
covered in foil to keep out ambient light, and the reaction stirred and allowed to warm to
ambient temperature over 16 h. The solution was concentrated in vacuo to give a pale
yellow solid containing the two diastereomeric cycloadducts 11 and 12 in an 8:1 ratio (as
judged by 1H NMR of the unpurified reaction mixture). The mixture was purified by flash
column chromatography on silica gel (gradient elution: 20% → 100% EtOAc in hexanes)
to afford pure 11 (144 mg, 58% yield) and 12 (18 mg, 7% yield) as pale yellow solids: 11:
TLC (60% EtOAc in hexanes) Rf: 0.23 (UV, CAM); m.p. 126.4-128.2 °C; IR(film, cm-1)
2981, 1865, 1781, 1688, 1631, 1450, 1368, 1252, 1216, 1155, 1076, 917, 727; 1H NMR
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(400 MHz, CDCl3) δ 8.06 (d, J= 7 Hz, 1H), 7.83 (dd, J= 7 Hz, 1.6 Hz, 1H), 7.74 (s, 1H),
7.26 (td, J= 7.1 Hz, 1.6 Hz, 1H), 7.23 (td, J= 7.4 Hz, 1.6 Hz, 1H), 3.88 (dd, J= 14.5 Hz, 0.8
Hz, 1H), 3.70 (s, 3H), 3.62 (d, J= 14.5 Hz, 1H), 3.60 (d, J= 8.6 Hz, 1H), 3.45 (m, 1H), 3.38
(d, J= 8.2 Hz, 1H), 3.35 (m, 1H), 2.68 (dt, J= 14.1 Hz, 7.4 Hz, 1H), 2.48 (dt, J= 14.1 Hz,
7.1 Hz, 1H), 2.03 (m, 2H), 1.67 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 169.5, 168.3, 167.6,
167.2, 149.9, 134.8, 132.0, 126.2, 123.8, 122.0, 120.7, 116.0, 114.8, 83.2, 69.2, 65.4,
55.4, 51.2, 47.6, 43.9, 28.2, 27.2, 25.7, 23.9; exact mass calc’d for C26H24N3O7Na [M +
Na]+ 516.1741, found 516.1740. 12: TLC (60% EtOAc in hexanes) Rf: 0.33UV, CAM); m.p.
114.3-115.5 °C; IR (film, cm-1) 2977, 1870, 1780, 1683, 1631, 1451, 1368, 1254, 1217,
1154, 1076, 920, 728; 1H NMR (400 MHz, CDCl3) δ 8.12 (d, J= 7.8 Hz, 1H), 7.96 (d, J=
7.5 Hz, 1H), 7.79 (s, 1H), 7.29 (td, J= 7.8 Hz, 1.2 Hz, 1H), 7.21 (td, J=7.5 Hz, 0.9 Hz, 1H),
3.76 (d, J= 14.8 Hz, 1H), 3.76 (s, 3H), 3.59 (m, 1H), 3.57 (d, J= 15.3 Hz, 1H), 3.45 (d, J=
9.4 Hz, 1H), 3.29 (m, 1H), 3.12 (d, J= 9.4 Hz, 1H), 2.69 (m, 2H), 2.11 (m, 1H), 1.89 (m,
1H), 1.65 (s, 9H); 3C NMR (400 MHz, CDCl3) δ 171.8, 169.2, 167.8, 167.0, 149.7, 136.4,
131.7, 131.7, 126.1, 124.1, 122.0, 121.2, 115.3, 114.8, 83.5, 68.3, 65.8, 55.6, 48.0, 47.6,
44.4, 28.1, 26.0, 25.1, 24.6; exact mass calc’d for C26H24N3O7Na [M + Na]+ 516.1741,
found 516.1738.

8-Benzyl 7-methyl (6R*,7R*,8S*,8aR*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3yl)methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a(azenometheno)indolizine-7,8-dicarboxylate (13) and 7-Benzyl 8-methyl

38

(6R*,7R*,8S*,8aR*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-9-methoxy-5oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-(azenometheno)indolizine-7,8-dicarboxylate.
(14)
To a flame-dried reaction flask under N2 was added BnOH (232 μL, 2.23 mmol) and THF
(2 mL). The reaction vessel was then cooled to –78 °C, and a solution of n-BuLi (2.2 M in
hexanes, 932 μL, 2.03 mmol) was added. The LiOBn solution was added dropwise via
syringe to a second flask containing cycloadduct 11 (1.00 g, 2.03 mmol) in THF (17 mL)
at –78 °C. The reaction was stirred at –78 °C for 30 min, diluted with 20 mL of sat’d NH4Cl,
and extracted with CH2Cl2 (4 X 25 mL). The combined organic layers were washed with
sat’d aq NaHCO3, sat’d aq NaCl (100 mL), dried with anhydrous Na2SO4, filtered, and
concentrated in vacuo. The resulting solid was dissolved in PhMe (20 mL) and cooled to
0 °C and a solution of TMS-diazomethane (2M in hexanes, 1.22 mL, 2.44 mmol) and
MeOH (2 mL), were added. The reaction was stirred at 0 °C for 30 min before another
portion of TMS-diazaomethane (2M in hexanes, 0.61 mL, 1.22 mmol) was added, and the
reaction stirred at 0 °C for an additional 30 min. The reaction was concentrated in vacuo
to afford a mix of compounds 13 and 14 in a 6:1 ratio (as judged by the unpurified 1HNMR). The reaction mixture was purified by flash column chromatography on silica gel
(gradient elution: 20% → 100% EtOAc in hexanes) to afford pure 13 (599 mg, 48% yield)
and 14 (186 mg, 15% yield) as amorphous solids. The strucutre of products 13 and 14
were validated using HSQC and HMBC NMR correlations: 13 TLC (60% EtOAc in
hexanes) Rf: 0.49 (UV, CAM); IR (film, cm-1) 2972, 1779, 1726, 1680, 1636, 1451, 1369,
1310, 1256, 1155, 1082, 949, 733; 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J= 7.4 Hz, 1H),
7.76 (s, 1H), 7.74 (d, 1H), 7.34 (m, 5H), 7.21 (m, 2H), 5.06 (d, J= 12.1 Hz, 1H), 4.99 (d,
J= 12.1 Hz, 1H), 3.75 (s, 3H), 3.53 (d, J= 14.4 Hz, 1H), 3.49 (d, J= 11.0 Hz, 1H), 3.45 (m,
1H), 3.29 (d, 1H), 3.28 (m, 1H), 3.27 (s, 3H), 3.21 (d, J= 11 Hz, 1H), 2,82 (m, 1H), 1.92
(m, 3H), 1.63 (s, 9H);

C NMR (400 MHz, CDCl3) δ 170.0, 169.4, 169.2, 132.1, 132.0,

13
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131.9, 128.6, 128.4, 126.0, 123.6, 121.9, 120.4, 116.2, 114.7, 68.5, 67.1, 64.9, 54.8, 53.9,
51.6, 49.6, 43.5, 28.9, 28.2, 27.4, 24; exact mass calc’d for C34H38N308 [M + H]+ 616.2653,
found 616.2646. 14: TLC (80% EtOAc in hexanes) Rf: 0.59 (UV, CAM); 1H NMR (400
MHz, CDCl3) δ 8.07 (d, J= 6.9 Hz, 1H), 7.74 (s, 1H), 7.69 (d, J= 7.9 Hz, 1H), 7.25 (m, 7H),
5.01 (d, J= 12.1 Hz, 1H), 4.72 (d, J= 12.5 Hz, 1H), 3.76 (s, 3H), 3.56 (d, J= 14.8 Hz, 1H),
3.54 (d, J= 11.1 Hz, 1H), 3.45 (m, 1H), 3.38 (s, 3H), 3.29 (m, 1H), 3.25 (d, J= 14.8 Hz,
1H), 3.17 (d, J= 11.1 Hz, 1H), 2.83 (m, 1H), 1.92 (m, 3H), 1.63 (s, 9H) ;

13

C NMR (400

MHz, CDCl3) δ 170.2, 170.0, 169.7, 169.1, 149.9, 135.1, 132.2, 128.5, 128.4, 126.0, 123.6,
121.9, 120.6, 116.2, 114.7, 83.0, 68.5, 66.9, 64.9, 54.9, 53.6, 51.8, 49.9, 43.5, 28.8, 28.2,
27.4, 24.5.

8-Benzyl 7-methyl (6S*,7R*,8S*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3yl)methyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-7,8dicarboxylate. (15)
A dry reaction flask was charged with lactim ether 13 (261 mg, 0.424 mmol) and flushed
with N2 gas for 10 min, dissolved in CH2Cl2 (2.1 mL), and cooled to 0 °C. To the reaction
flask was added pTsOH·H2O (85 mg, 0.446 mmol), and the reaction was stirred for 7 h at
0 °C. The reaction mixture was diluted with sat’d aq NaHCO3 (10 mL) and extracted with
CH2Cl2 (4 X 10 mL). The combined organic layers were washed with sat’d aq NaCl (40
mL), dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. The resulting
product was dissolved in toluene (2.1 mL) and stirred at 80 °C for 18 h. The solution was
concentrated in vacuo to afford lactam 15 as a white solid. The unpurified product was
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purified by flash column chromatography on silica gel (gradient elution: 40% → 100%
EtOAc in hexanes) to afford pure lactam 15 as a yellow oil (195 mg, 77% yield): TLC (60%
EtOAc in hexanes) Rf: 0.47 (UV, CAM);

IR (film, cm-1) 2986, 2244, 1695, 1458, 1368,

1257, 1153, 1079, 907, 726; 1H NMR (400 MHz, CDCl3) δ 8.11 (d, J= 7.9 Hz, 1H), 7.68 (s,
1H), 7.66 (d, J= 3.6 Hz, 1H), 7.31 (m, 8H), 5.98 (s, 1H), 5.12 (d, J= 12.1 Hz, 1H), 5.08 (d,
J= 12.1 Hz, 1H), 3.67 (d, J= 14.5 Hz, 1H), 3.56 (m, 1H), 3.44 (m, 1H), 3.40 (s, 3H), 3.35
(d, J= 8.2 Hz, 1H), 3.33 (d, J= 14.5 Hz, 1H), 2.79 (m, 1H), 1.97 (m, 1H), 1.85 (m, 1H), 1.67
(s, 9H);

C NMR (400 MHz, CDCl3) δ 169.1, 169.0, 168.4, 167.2, 149.5, 135.1, 134.8,

13

131.0, 128.7, 128.6, 126.9, 124.6, 122.9, 118.7, 115.3, 112.8, 83.7, 68.0, 67.5, 63.2, 52.4,
51.9, 48.6, 44.4, 28.4, 28.2, 24.3, 23.4; MASS SPEC SAMPLE NEEDS TO BE
SUBMITTED.

(6S*,7R*,8S*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-7(methoxycarbonyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-8carboxylic acid. (16)
Lactam 15 (364 mg, 0.607 mmol) was dissolved in EtOAc (6 mL) at rt, and 10% Pd/C (65
mg) was added. One balloon of H2 gas was used to sparge the reaction mixture for 10
min, and another balloon of H2 gas was left above the reaction to maintain an atmosphere
of H2. The reaction mixture was stirred at rt for 1 h before the reaction mixture was filtered
through Celite, and the filter pad was washed with EtOAc (3 X 10 mL). The filtered solution
was then concentrated in vacuo to afford carboxylic acid 16 (285 mg, 92% yield) as a
white solid that was used without further purification: TLC (5% MeOH in CHCl3 with 1%
AcOH) Rf: 0.22 (UV, CAM); IR (film, cm-1) 3366, 2970, 2891, 1736, 1680, 1453, 1368,
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1309, 1257, 1158, 1128, 1081, 949, 816, 747; 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=
7.8 Hz, 1H), 7.69 (d, J= 7.4 Hz, 1H), 7.67 (s, 1H), 7.29 (m, 2H), 6.57 (s, 1H), 6.57 (s-broad,
1H), 3.68 (d, J= 14.8 Hz, 1H), 3.65 (s, 3H), 3.51 (m, 2H), 3.45 (d, J= 14.5 Hz, 1H), 3.40
(d, J= 11.3 Hz, 1H), 3.36 (d, J= 11.4 Hz, 1H), 2.77 (m, 1H), 2.00 (m, 3H), 1.67 (s, 9H); 13C
NMR (400 MHz, CDCl3) δ 169.6, 167.3, 149.6, 135.1, 131.1, 126.9, 124.5, 122.8, 119.0,
115.3, 113.0, 83.8, 68.2, 63.4, 52.6, 52.3, 48.4, 44.5, 28.3, 28.2, 24.3, 23.6; exact mass
calc’d for C26H30N3O8 [M + H]+ 512.2027, found 512.2030.

8-(1,3-dioxoisoindolin-2-yl) 7-methyl (6S*,7R*,8S*,8aS*)-6-((1-(tert-butoxycarbonyl)1H-indol-3-yl)methyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)indolizine7,8-dicarboxylate. (17)
A dry flask was charged with carboxylic acid 16 (100 mg, 0.196 mmol), flushed with N2
gas for 10 min, dissolved in CH2Cl2 (4 mL), and cooled to 0°C. EDC (56 mg, 0.294 mmol),
DMAP (5 mg, 0.039 mmol), and N-hydroxylphthalimide (48 mg, 0.294 mmol) were added
to the flask as solids, and the reaction was stirred and allowed to warm to rt over 6 h. The
reaction mixture was diluted with 0.1 M HCl (20 mL) and extracted with CH2Cl2 (3 X 15
mL). The combined organic layers were washed with sat’d aq NaHCO3 (25 mL), sat’d aq
NaCl (25 mL), dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to afford
phthalimidoyl ester 17 as a mixture containing excess N-hydroxyl phthalimide and EDC
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by-products. The unpurified product was purified by flash column chromatography on silica
gel (gradient elution: 10% → 80% EtOAc in hexanes) to afford pure 17 (104 mg, 80%
yield) as a white solid: TLC (60% EtOAc in hexanes) Rf: 0.64 (UV, CAM); m.p. 162.4164.3 °C; IR (film, cm-1) 2971, 1814, 1784, 1743, 1700, 1452, 1369, 1257, 1155, 1080,
1017, 977, 911, 877, 729, 695; 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J= 7.8 Hz, 1H), 7.90
(m, 2H), 7.83 (m, 2H), 7.69 (s, 1H), 7.59 (dd, J= 6.7 Hz, 1.2 Hz, 1H), 7.33 (td, J= 7.4 Hz,
1.5 Hz, 1H), 7.29 (td, J= 7 Hz, 1.2 Hz, 1H), 5.96 (s, 1H), 3.88 (s, 3H), 3.78 (d, J= 14.8 Hz,
1H), 3.60 (m, 1H), 3.56 (d, J= 5.9 Hz, 1H), 3.48 (m, 1H), 3.47 (d, J= 5.8 Hz, 1H), 3.29 (d,
J= 14.8 Hz, 1H), 2.90 (ddd, J= 13.3 Hz, 7.9 Hz, 4.7 Hz, 1H), 2.42 (td, J= 14.1 Hz, 8.2 Hz,
1H), 2.15 (m, 1H), 1.96 (m, 1H), 1.67 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 170.0, 169.3,
167.4, 166.3, 149.5, 135.2. 135.1, 134.2, 130.9, 128.7, 127.1, 124.7, 124.2, 123.4, 123.1,
118.3, 115.5, 112.3, 83.9, 68.5, 63.6, 52.9, 50.7, 47.8, 45.1, 28.2, 26.6, 24.1, 23.2; exact
mass calc’d for C34H33N4O10 [M + H]+ 657.2191, found 657.1828.

Methyl (6S*,7R*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-5,9dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-7-carboxylate. (18)
A flame-dried flask was charged with phthalimidoyl ester 17 (36 mg, 0.054 mmol), flushed
with N2 gas for 10 min, and dissolved in CH3CN (1 mL). To the reaction vessel was added
Hantzsch ester (15 mg, 0.059 mmol), AIBN (1 mg, 0.0054 mmol), and t-BuSH (30 μL,
0.268 mmol), and the reaction vessel was fitted with a reflux condenser. The reaction was
stirred and heated at 80 °C for 1 h. The reaction mixture was diluted with sat’d aq NaHCO3
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(10 mL) and extracted with CH2Cl2 (3 X 10 mL). The combined organic layers were washed
with sat’d aq NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated in
vacuo to give decarboxylated product 18. The product was purified by flash column
chromatography on silica gel (gradient elution: 20% → 100% EtOAc in hexanes) to afford
pure 18 (15 mg, 60% yield) as a colorless oil. The structure of 18 was validated by
comparison to known material: TLC (80% EtOAc in hexanes) Rf: 0.46 (UV, CAM); IR (film,
cm-1) 2978, 1786, 1745, 1733, 1452, 1370, 1256, 1159, 1084; 1H NMR (400 MHz, CDCl3)
δ 8.13 (d, J= 7.9 Hz, 1H), 7.64 (s, 1H), 7.57 (dd, J= 7.1 Hz, 1.2 Hz, 1H), 7.32 (td, J= 7.1
Hz, 1.2 Hz, 1H), 7.27 (td, J= 7.4 Hz, 1.2 Hz, 1H), 5.83 (s, 1H), 3.76 (s, 3H), 3.70 (d, J=
14.9 Hz, 1H), 3.51 (d, J= 15.2 Hz, 1H), 3.51 (m, 1H), 3.15 (d, J= 14.9 Hz, 1H), 3.05 (dd,
J= 10.4 Hz, 4.9 Hz, 1H), 2.73 (dt, J= 13.3 Hz, 6.7 Hz, 1H), 2.28 (dd, J= 13.5 Hz, 10.3 Hz,
1H), 2.18 (dd, J= 13.7 Hz, 5.1 Hz, 1H), 2.00 (m, J= 7.0 Hz, 2H), 1.80 (dt, J= 13.3 Hz, 7.0
Hz, 1H), 1.67 (s, 9H);13C NMR (400 MHz, CDCl3) δ 171.9, 171.6, 167.2, 131.0, 126.8,
124.7, 123.0, 118.3, 115.5, 112.9, 83.8, 66.7, 63.9, 53.4, 52.3, 46.0, 44.3, 36.1, 28.9, 28.2,
24.3, 23.5; exact mass calc’d for C25H30N3O6 [M + H]+ 468.2129, found 468.2127.
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